ScholarIQanswers from OpenAlex & ORCID
Emma Guttman‐Yassky
ResearcherPublications, citations & collaboration network
Emma Guttman‐Yassky is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Emma Guttman‐Yassky have?
ScholarIQindexed works
Emma Guttman‐Yassky has 764 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Emma Guttman‐Yassky have?
ScholarIQcitation count
Emma Guttman‐Yassky has 47,254 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Emma Guttman‐Yassky?
ScholarIQh-index
Emma Guttman‐Yassky has an h-index of 116 in OpenAlex.
What is the i10-index of Emma Guttman‐Yassky?
ScholarIQi10-index
Emma Guttman‐Yassky has an i10-index of 376 in OpenAlex.
What is the ORCID of Emma Guttman‐Yassky?
ScholarIQorcid
The ORCID for Emma Guttman‐Yassky is on the source record.
What is the OpenAlex record for Emma Guttman‐Yassky?
ScholarIQopenalex
The OpenAlex for Emma Guttman‐Yassky is on the source record.
What are the most-cited papers on Emma Guttman‐Yassky?
ScholarIQmost cited works
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton, Neil M.H. Graham, Thomas Bieber, Ross E. Rocklin, Jeffrey E. Ming, Haobo Ren, Richard Kao, Eric L. Simpson, Marius Ardeleanu, Steven P. Weinstein, Gianluca Pirozzi, Emma Guttman‐Yassky, Mayte Suárez‐Fariñas, Melissa Hager, Neil Stahl, George D. Yancopoulos, Allen Radin
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman‐Yassky, Robert Bissonnette, Benjamin Ungar, Mayte Suárez‐Fariñas, Marius Ardeleanu, Hitokazu Esaki, Maria Suprun, Yeriel Estrada, Hui Xu, Xiangyu Peng, Jonathan I. Silverberg, Alan Menter, James G. Krueger, Rick Zhang, Usman Chaudhry, Brian N. Swanson, Neil M.H. Graham, Gianluca Pirozzi, George D. Yancopoulos, Jennifer D. Hamilton
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
Andreas Wollenberg, Andrew Blauvelt, Emma Guttman‐Yassky, Margitta Worm, Charles Lynde, J.‐P. Lacour, Lynda Spelman, Norito Katoh, Hidehisa Saeki, Yves Poulin, Aleksandra Lesiak, Leon Kircik, S.H. Cho, Pedro Herranz, Michael J. Cork, Ketty Peris, Louise Abildgaard Steffensen, B K Bang, Alexandra Kuznetsova, T.N. Jensen, Marie Louise Østerdal, Eric L. Simpson, the ECZTRA 1 and ECZTRA 2 study investigators
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
Thomas Werfel, Jean‐Pierre Allam, Tilo Biedermann, Kilian Eyerich, Stefanie Gilles, Emma Guttman‐Yassky, Wolfram Hoetzenecker, Edward F. Knol, Hans‐Uwe Simon, Andreas Wollenberg, Thomas Bieber, Roger Lauener, Peter Schmid‐Grendelmeier, Claudia Traidl‐Hoffmann, Cezmi A. Akdiş